The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease
Abstract
The dying forward hypothesis of motor neuron disease (MND) suggests that corticomotoneurons induce excitotoxic anterior horn cell death, with involvement of the glutamatergic neurotransmitter system. The aim of the present study was to apply novel threshold tracking transcranial magnetic stimulation (TMS) techniques in conjunction with peripheral nerve excitability studies in MND patients to further investigate the dying forward hypothesis and possibly determine the site of disease onset. Studies were undertaken in 23 MND patients using a 90-mm circular coil connected to a BiStim magnetic stimulator for cortical studies and electrical stimulation for peripheral nerve excitability studies. Motor-evoked potentials and compound muscle action potentials (CMAPs) were recorded from the right abductor pollicis brevis in the same setting. Measures of cortical and peripheral nerve excitability were correlated with clinical and neurophysiological parameters of disease severity. Short-interval intracortical inhibition (SICI) was significantly reduced in MND patients compared with controls (MND group = 3.6 +/- 0.8%; controls = 8.5 +/- 1.0%, P < 0.001), most prominently in MND patients with limb-onset disease. Changes in intracortical inhibition were accompanied by alterations in the magnetic stimulus-response curve, cortical silent period duration and resting motor threshold, all indicative of cortical hyperexcitability. Although the reduction in SICI was more pronounced in MND patients with less severe disease, as assessed by the CMAP amplitude, it remained evident even in MND patients with advanced disease. Measures of peripheral disease burden, namely the CMAP amplitude (r = -0.6) and neurophysiological index (r = -0.6), correlated with cortical hyperexcitability changes, as did the strength-duration time constant (r = -0.6), a peripheral marker of axonal excitability. Simultaneous assessment of central and peripheral nerve excitability has established the presence of co-existent upper and lower motor neuron dysfunction, with cortical hyperexcitability an early feature in MND.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis
Brooks, B. R., Miller, R. G., Swash, M., & Munsat, T. L. (2000) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608200300079536 · Cited by 5,433
Cedarbaum, J. M., Stambler, N., Malta, E., Fuller, C., Hilt, D., Thurmond, B., & Nakanishi, A. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(99)00210-5 · Cited by 3,307
Corticocortical inhibition in human motor cortex.
Kujirai, T., Caramia, M. D., Rothwell, J. C., Day, B. L., Thompson, P. D., Ferbert, A., Wroe, S., Asselman, P., & Marsden, C. D. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019912 · Cited by 3,131
A Controlled Trial of Riluzole in Amyotrophic Lateral Sclerosis
Bensimon, G., Lacomblez, L., & Meininger, V. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300901 · Cited by 2,233
Bruijn, L. I., Becher, M. W., Lee, M. K., Anderson, K. L., Jenkins, N. A., Copeland, N. G., Sisodia, S. S., Rothstein, J. D., Borchelt, D. R., Price, D. L., et al. (1997) · Neuron · doi:10.1016/s0896-6273(00)80272-x · Cited by 1,341
Dose-ranging study of riluzole in amyotrophic lateral sclerosis
Amyotrophic Lateral Sclerosis/Riluzole Study Group II, Lacomblez, L., Bensimon, G., Meininger, V, Leigh, P. N., & Guillet, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91680-3 · Cited by 1,301
Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)
Miller, R. G., Mitchell, J. D., & Moore, D. H. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001447.pub3 · Cited by 1,058
Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans
Werhahn, K. J., Kunesch, E., Noachtar, S., Benecke, R., & Classen, J. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0591t.x · Cited by 887
The effect of lorazepam on the motor cortical excitability in man
Ziemann, U., L�nnecker, S., Steinhoff, B., & Paulus, W. (1996) · Experimental Brain Research · doi:10.1007/bf00228633 · Cited by 791
Silent period evoked by transcranial stimulation of the human cortex and cervicomedullary junction.
Inghilleri, M., Berardelli, A., Cruccu, G., & Manfredi, M. (1993) · The Journal of Physiology · doi:10.1113/jphysiol.1993.sp019732 · Cited by 785
Turner, M. R., Cagnin, A., Turkheimer, F. E., Miller, C. C. J., Shaw, C. E., Brooks, D. J., Leigh, P. N., & Banati, R. B. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.12.012 · Cited by 737
Ziemann, U. (2004) · Clinical Neurophysiology · doi:10.1016/j.clinph.2004.03.006 · Cited by 629
Chronic inhibition of glutamate uptake produces a model of slow neurotoxicity.
Rothstein, J. D., Jin, L., Dykes-Hoberg, M., & Kuncl, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6591 · Cited by 623
Threshold tracking techniques in the study of human peripheral nerve
Bostock, H., Cikurel, K., & Burke, D. (1998) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(199802)21:2<137::aid-mus1>3.0.co;2-c · Cited by 582
Connors, B. W., Malenka, R. C., & Silva, L. R. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017390 · Cited by 522
Magnetic brain stimulation: The silent period after the motor evoked potential
MD, R. C., MD, M. G., MD, C. C., & MD, R. M. (1992) · Neurology · doi:10.1212/wnl.42.10.1951 · Cited by 478
Multiple measures of axonal excitability: A new approach in clinical testing
Kiernan, M. C., Burke, D., Andersen, K. V., & Bostock, H. (2000) · Muscle & Nerve · doi:10.1002/(sici)1097-4598(200003)23:3<399::aid-mus12>3.0.co;2-g · Cited by 457
Burke, D., Kiernan, M. C., & Bostock, H. (2001) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00595-8 · Cited by 444
Two phases of intracortical inhibition revealed by transcranial magnetic threshold tracking
Fisher, R. J., Nakamura, Y., Bestmann, S., Rothwell, J. C., & Bostock, H. (2002) · Experimental Brain Research · doi:10.1007/s00221-001-0988-2 · Cited by 403
Mechanism of the silent period following transcranial magnetic stimulation
Chen, R., Lozano, A. M., & Ashby, P. (1999) · Experimental Brain Research · doi:10.1007/s002210050878 · Cited by 394
Trotti, D., Rolfs, A., Danbolt, N. C., Brown, R. H., & Hediger, M. A. (1999) · Nature Neuroscience · doi:10.1038/8091 · Cited by 373
Strength-duration properties of human peripheral nerve
Mogyoros, I., Kiernan, M. C., & Burke, D. (1996) · Brain · doi:10.1093/brain/119.2.439 · Cited by 358
Self-citationLeigh, P. N., & Ray-Chaudhuri, K. (1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.8.886 · Cited by 331
Latent addition in motor and sensory fibres of human peripheral nerve.
Bostock, H., & Rothwell, J. C. (1997) · The Journal of Physiology · doi:10.1113/jphysiol.1997.sp021857 · Cited by 317
Sur la possibilite de rendre comparables entre eux les appareils servant a l'excitation electrique.
Weiss, G. (1990) · ARCHIVES ITALIENNES DE BIOLOGIE · doi:10.4449/aib.v35i1.1355 · Cited by 283
The glutamate antagonist Riluzole suppresses intracortical facilitation
Liepert, J., Schwenkreis, P., Tegenthoff, M., & Malin, J. P. (1997) · Journal of Neural Transmission · doi:10.1007/bf01294721 · Cited by 274
Two phases of short-interval intracortical inhibition
Roshan, L., Paradiso, G. O., & Chen, R. (2003) · Experimental Brain Research · doi:10.1007/s00221-003-1502-9 · Cited by 238
Amyotrophic lateral sclerosis (ALS): A phylogenetic disease of the corticomotoneuron?
Eisen, A., Kim, S., & Pant, B. (1992) · Muscle & Nerve · doi:10.1002/mus.880150215 · Cited by 237
Electrical stimulation over the human vertebral column: which neural elements are excited?
Mills, K. R., & Murray, N. M. F. (1986) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(86)90145-8 · Cited by 231
Ziemann, U., Winter, M., Reimers, C. D., Reimers, K., Tergau, F., & Paulus, W. (1997) · Neurology · doi:10.1212/wnl.49.5.1292 · Cited by 230
Kuo, J. J., Siddique, T., Fu, R., & Heckman, C. J. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.074138 · Cited by 225
Patterns of neuronal degeneration in the motor cortex of amyotrophic lateral sclerosis patients
Nihei, K., McKee, A. C., & Kowall, N. W. (1993) · Acta Neuropathologica · doi:10.1007/bf00454899 · Cited by 225
Bostock, H. (1983) · The Journal of Physiology · doi:10.1113/jphysiol.1983.sp014792 · Cited by 223
Handbook of clinical neurophysiology
Daube, J. R., & Mauguı̀ere, F. (2003) · Elsevier eBooks · Cited by 222
Activation of the Insular Cortex During Dynamic Exercise in Humans
Williamson, J. W., Nobrega, A. C. L., McColl, R., Mathews, D., Winchester, P., Friberg, L., & Mitchell, J. H. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.277bh.x · Cited by 199
Assessment of cortical excitability using threshold tracking techniques
Vucic, S., Howells, J., Trevillion, L., & Kiernan, M. C. (2006) · Muscle & Nerve · doi:10.1002/mus.20481 · Cited by 190
Self-citationThe motor cortex and amyotrophic lateral sclerosis
Eisen, A., & Weber, M. (2001) · Muscle & Nerve · doi:10.1002/mus.1042 · Cited by 188
Caramia, M. D., Cicinelli, P., Paradiso, C., Mariorenzi, R., Zarola, F., Bernardi, G., & Rossini, P. M. (1991) · Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section · doi:10.1016/0168-5597(91)90009-m · Cited by 187
CHANGES IN SIZES OF CORTICAL AND LOWER MOTOR NEURONS IN AMYOTROPHIC LATERAL SCLEROSIS
KIERNAN, J. A., & HUDSON, A. J. (1991) · Brain · doi:10.1093/brain/114.2.843 · Cited by 185
Axonal ion channel dysfunction in amyotrophic lateral sclerosis
Bostock, H., Sharief, M. K., Reid, G., & Murray, N. M. F. (1995) · Brain · doi:10.1093/brain/118.1.217 · Cited by 185
Strength-duration properties of sensory and motor axons in amyotrophic lateral sclerosis
Mogyoros, I. (1998) · Brain · doi:10.1093/brain/121.5.851 · Cited by 179
Effects of temperature on the excitability properties of human motor axons
Kiernan, M. C. (2001) · Brain · doi:10.1093/brain/124.4.816 · Cited by 178
Cortical Excitability in Amyotrophic Lateral Sclerosis: A Clue to Pathogenesis
Eisen, A., Pant, B., & Stewart, H. (1993) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s031716710004734x · Cited by 175
Ipsilateral cortico-cortical inhibition of the motor cortex in various neurological disorders
Hanajima, R., Ugawa, Y., Terao, Y., Ogata, K., & Kanazawa, I. (1996) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(96)00100-1 · Cited by 163
Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis
Zanette, G., Tamburin, S., Manganotti, P., Refatti, N., Forgione, A., & Rizzuto, N. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(02)00288-2 · Cited by 162
Central motor conduction: Method and normal results
Claus, D. (1990) · Muscle & Nerve · doi:10.1002/mus.880131207 · Cited by 157
Clinical evaluation of excitability measures in sensory nerve
Kiernan, M. C., Lin, C. S.-Y., Kv, A., Murray, N. M. F., & Bostock, H. (2001) · Muscle & Nerve · doi:10.1002/mus.1085 · Cited by 154
The cortical silent period and amyotrophic lateral sclerosis
Prout, A. J. E., & Eisen, A. (1994) · Muscle & Nerve · doi:10.1002/mus.880170213 · Cited by 134
The natural history of central motor abnormalities in amyotrophic lateral sclerosis
Mills, K. R. (2003) · Brain · doi:10.1093/brain/awg260 · Cited by 133
Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease
Triggs, W. J., Menkes, D. L., Onorato, J., Yan, R. S. H., Young, M. S., Newell, K., Sander, H. W., Soto, O., Chiappa, K. H., & Cros, D. (1999) · Neurology · doi:10.1212/wnl.53.3.605 · Cited by 132
Kanai, K. (2003) · Brain · doi:10.1093/brain/awg073 · Cited by 121
Double cortical stimulation in amyotrophic lateral sclerosis.
Yokota, T., Yoshino, A., Inaba, A., & Saito, Y. (1996) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.61.6.596 · Cited by 119
Comparison of intracortical inhibition and facilitation in distal and proximal arm muscles in humans
Abbruzzese, G., Assini, A., Buccolieri, A., Schieppati, M., & Trompetto, C. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.895ad.x · Cited by 97
Quantification of upper motor neuron loss in amyotrophic lateral sclerosis
Rösler, K. M., Truffert, A., Hess, C. W., & Magistris, M. R. (2000) · Clinical Neurophysiology · doi:10.1016/s1388-2457(00)00481-8 · Cited by 93
Recurrent inhibition is decreased in patients with amyotrophic lateral sclerosis
Raynor, E. M., & Shefner, J. M. (1994) · Neurology · doi:10.1212/wnl.44.11.2148 · Cited by 85
Effects of riluzole on cortical excitability in patients with amyotrophic lateral sclerosis
Stefan, K., Kunesch, E., Benecke, R., & Claßen, J. (2001) · Annals of Neurology · doi:10.1002/ana.107 · Cited by 85
Kohara, N., Kaji, R., Kojima, Y., Mills, K. R., Fujii, H., Hamano, T., Kimura, J., Takamatsu, N., & Uchiyama, T. (1996) · Electroencephalography and Clinical Neurophysiology/Electromyography and Motor Control · doi:10.1016/0013-4694(95)00166-2 · Cited by 71
Desiato, M. T., Bernardi, G., Abdikarim Hagi, H., Boffa, L., & Caramia, M. D. (2002) · Clinical Neurophysiology · doi:10.1016/s1388-2457(01)00724-6 · Cited by 63
Cytoskeletal pathology in motor neuron diseases.
Pn, L., & Swash, M. (1991) · PubMed · Cited by 63
Motor neuron disease: A primary disorder of corticomotoneurons?
Pamphlett, R., Kril, J. J., & Hng, T. (1995) · Muscle & Nerve · doi:10.1002/mus.880180308 · Cited by 59
Sommer, M., Tergau, F., Wischer, S., Reimers, C. D., Beuche, W., & Paulus, W. (1999) · Journal of Neurology · doi:10.1007/bf03161086 · Cited by 45
Electrophysiologic evaluation of upper motor neuron involvement in amyotrophic lateral sclerosis
Drory, V. E., Kovach, I., & Groozman, G. B. (2001) · Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders · doi:10.1080/146608201753275616 · Cited by 42
Clinical Neurophysiology of Motor Neuron Diseases
(2004) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(00)x0003-2 · Cited by 37
Cortical threshold and excitability measurements
Ziemann, U. (2004) · Handbook of clinical neurophysiology · doi:10.1016/s1567-4231(04)04017-1 · Cited by 32
de Carvalho, M. A., Lopes, A., Scotto, M. G., & Swash, M. (2001) · Muscle & Nerve · doi:10.1002/mus.1161 · Cited by 31
Riluzole: a glimmer of hope in the treatment of motor neurone disease
Kiernan, M. C. (2005) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2005.tb06727.x · Cited by 10
Cited by
Clinical diagnosis and management of amyotrophic lateral sclerosis
Hardiman, O., van den Berg, L. H., & Kiernan, M. C. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.153 · Cited by 621
Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis
Ferraiuolo, L., Kirby, J., Grierson, A. J., Sendtner, M., & Shaw, P. J. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.152 · Cited by 615
Cortical hyperexcitability may precede the onset of familial amyotrophic lateral sclerosis
Vucic, S., Nicholson, G. A., & Kiernan, M. C. (2008) · Brain · doi:10.1093/brain/awn071 · Cited by 460
Self-citationBiomarkers in amyotrophic lateral sclerosis
Turner, M. R., Kiernan, M. C., Leigh, P. N., & Talbot, K. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70293-x · Cited by 438
Motor Neuron dysfunction in frontotemporal dementia
Burrell, J. R., Kiernan, M. C., Vucic, S., & Hodges, J. R. (2011) · Brain · doi:10.1093/brain/awr195 · Cited by 348
Self-citation
Metadata
- Authors
- Vucic, S.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-09-01
- Volume
- 129
- Issue
- 9
- Pages
- 2436-2446
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2117890656
- Cited by
- 334
- References
- 67
- FWCI
- 5.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.